# Weight-loss associated DNA methylation patterns: targetable biomarkers and pathway insights

**Authors:** Longjin Zeng, Xu Chen, Longyao Zhang, Yaxian Qi, Lingchen Li, Chenrui Yin, Jianguo Sun

PMC · DOI: 10.1186/s13104-025-07324-x · BMC Research Notes · 2025-07-22

## TL;DR

This study identifies DNA methylation patterns linked to weight loss after bariatric surgery and highlights potential targets for cancer treatment.

## Contribution

The study introduces conserved DNA methylation probes and a pathway enrichment score linked to weight loss and cancer.

## Key findings

- KCNB1, PEAK1, SCG5, and TNIK are key DNA methylation targets confirmed by mouse data and druggability resources.
- A positive correlation exists between chromosomal instability scores and the pathway enrichment score in tumor tissues.
- Upstream molecular drivers may influence methylation patterns associated with weight loss and cancer progression.

## Abstract

Weight loss is a firmly established negative survival factor for individuals with cancer, yet effective biomarkers and targeted therapies remain elusive. In this study, we collected skeletal muscle, noncancerous, and cancerous tissues using the Illumina EPIC array to identify conserved DNA methylation probes associated with weight loss following bariatric surgery. Next, the consistency of the probes is evaluated and then the probes are integrated into a generalizable pathway enrichment score. Our results emphasize the gene-centered design, identifying KCNB1, PEAK1, SCG5, and TNIK as key targets of DNA methylation, as confirmed by mouse phenotype data and druggability resources. Moreover, an illustrative test of protein abundance in cell lines is conducted. Utilizing the Clinical Proteomic Tumor Analysis Consortium data, a positive correlation is established between the chromosomal instability scores and our generated score in tumor tissues. In addition, considering these correlation findings, the presence of identifiable methylation blocks in the co-occurring gain samples. Our findings also suggest that upstream molecular drivers may influence this pathway enrichment score, potentially leading to dysregulated methylation associated with weight loss. In summary, DNA methylation analysis not only identifies functional targets but also uncovers new gene-disease connections.

The online version contains supplementary material available at 10.1186/s13104-025-07324-x.

## Linked entities

- **Genes:** KCNB1 (potassium voltage-gated channel subfamily B member 1) [NCBI Gene 3745], PEAK1 (pseudopodium enriched atypical kinase 1) [NCBI Gene 79834], SCG5 (secretogranin V) [NCBI Gene 6447], TNIK (TRAF2 and NCK interacting kinase) [NCBI Gene 23043]

## Full-text entities

- **Genes:** Kcnb1 (potassium voltage gated channel, Shab-related subfamily, member 1) [NCBI Gene 16500] {aka Kcr1-1, Kv2.1, Shab}, Tnik (TRAF2 and NCK interacting kinase) [NCBI Gene 665113] {aka 1500031A17Rik, 4831440I19Rik, C530008O15Rik, C630040K21Rik}, Scg5 (secretogranin V) [NCBI Gene 20394] {aka 7B2, Sgne-1, Sgne1}, Peak1 (pseudopodium-enriched atypical kinase 1) [NCBI Gene 244895] {aka 1110049L02Rik, 9530046P14, C230081A13Rik, SGK269, mKIAA2002}
- **Diseases:** Weight loss (MESH:D015431), Tumor (MESH:D009369)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12281797/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12281797/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12281797/full.md

---
Source: https://tomesphere.com/paper/PMC12281797